General Information of the Compound
Compound ID
CP0259062
Compound Name
(S)-2-Methyl-3-{4-[2-(5-methyl-2-thiophen-2-yl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid
    Show/Hide
Synonyms
Dual PPAR-alpha/PPAR-gamma agonists
LY-510929
LY-929
    Show/Hide
Structure
Formula
C26H25NO5S
Molecular Weight
463.555
Canonical SMILES
Cc1oc(nc1CCOc1ccc(C[C@](C)(Oc2ccccc2)C(O)=O)cc1)-c1cccs1
    Show/Hide
InChI
InChI=1S/C26H25NO5S/c1-18-22(27-24(31-18)23-9-6-16-33-23)14-15-30-20-12-10-19(11-13-20)17-26(2,25(28)29)32-21-7-4-3-5-8-21/h3-13,16H,14-15,17H2,1-2H3,(H,28,29)/t26-/m0/s1
    Show/Hide
InChIKey
KWSPYUOBNIMILB-SANMLTNESA-N
Physicochemical Property
logP
5.79782
Rotatable Bonds
10
Heavy Atom Count
33
Polar Areas
81.79
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9890585
SID: 22395214
ChEMBL ID
CHEMBL77502
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000044 CV-1 Chlorocebus aethiops (Green monkey)  1
1
EC50 = 9 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 8.913 nM
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000044 CV-1 Chlorocebus aethiops (Green monkey)  1
1
EC50 = 4 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 3.981 nM
Clinical Information about the Compound
Drug 1 ( LY-929 )
Drug Name LY-929
Company Ligand Pharmaceuticals Inc
Indication
Lipid metabolism disorder
Discontinued in Phase 1
Target(s)
Peroxisome proliferator-activated receptor gamma (PPAR-gamma)
Agonist
Peroxisome proliferator-activated receptor alpha (PPARA)
Agonist